Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
Authors
Keywords
-
Journal
INFLAMMOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-31
DOI
10.1007/s10787-022-01027-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19
- (2022) Gomaa Mostafa-Hedeab et al. INFLAMMOPHARMACOLOGY
- PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking
- (2021) Claire Lugnier et al. BIOCHEMICAL PHARMACOLOGY
- Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects
- (2021) Hayder M. Al-kuraishy et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Hyperoxia and Lungs: What We Have Learned From Animal Models
- (2021) Luciano Amarelle et al. Frontiers in Medicine
- COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
- (2021) Hayder M. Al-kuraishy et al. Frontiers in Medicine
- Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh
- (2021) Reaz Mahmud et al. PLoS One
- The Looming Effects of Estrogen in Covid-19: A Rocky Rollout
- (2021) Hayder M. Al-kuraishy et al. Frontiers in Nutrition
- Acute kidney injury and COVID-19
- (2021) Hayder M. Al-kuraishy et al. The Egyptian Journal of Internal Medicine
- TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation
- (2020) Aja Aravamudhan et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK
- (2020) Mark Hamer et al. BRAIN BEHAVIOR AND IMMUNITY
- Abnormal pulmonary function in COVID-19 patients at time of hospital discharge
- (2020) Xiaoneng Mo et al. EUROPEAN RESPIRATORY JOURNAL
- Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
- (2020) Hai-qiong Yu et al. EUROPEAN RESPIRATORY JOURNAL
- Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19
- (2020) Hisashi Kai et al. HYPERTENSION RESEARCH
- Can melatonin reduce the severity of COVID-19 pandemic?
- (2020) Alex Shneider et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Targeting potential drivers of COVID-19: Neutrophil extracellular traps
- (2020) Betsy J. Barnes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathway
- (2020) Chinmayee Goda et al. PLoS Genetics
- High-flow nasal cannula oxygen therapy in idiopathic pulmonary fibrosis patients with respiratory failure
- (2020) Ji-Hoon Lee et al. Journal of Thoracic Disease
- The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2
- (2020) Francesco Ferrara et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19
- (2020) Margot Combet et al. EUROPEAN RESPIRATORY JOURNAL
- Fatal pulmonary fibrosis: a post-COVID-19 autopsy case
- (2020) Hanna Ferløv Schwensen et al. JOURNAL OF CLINICAL PATHOLOGY
- p38 MAPK inhibition: A promising therapeutic approach for COVID-19
- (2020) Joseph M. Grimes et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Lung fibrosis: an undervalued finding in COVID-19 pathological series
- (2020) Federica Grillo et al. LANCET INFECTIOUS DISEASES
- Could Pirfenidone Also be Effective in Treating Intestinal Fibrosis?
- (2020) Giovanni Latella et al. Cells
- Pyrvinium pamoate induces in-vitro suppression of IL-6 and IL-8 produced by human endometriotic stromal cells
- (2020) Amin Karamian et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- YAP/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathways
- (2020) Ting Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm
- (2020) Laura Artigas et al. PLoS One
- The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial
- (2020) Pär Ingemar Johansson et al. Trials
- Healing after Covid-19: Are Survivors at Risk for Development of Pulmonary Fibrosis?
- (2020) Lindsay T McDonald AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
- (2020) Tamara S. Rodrigues et al. JOURNAL OF EXPERIMENTAL MEDICINE
- YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF
- (2019) Yingzhun Chen et al. CELL DEATH AND DIFFERENTIATION
- Costunolide inhibits pulmonary fibrosis via regulating NF-kB and TGF-β1/Smad2/Nrf2-NOX4 signaling pathways
- (2019) Bin Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Correlation analysis between mechanical power, transforming growth factor-β1, and connective tissue growth factor levels in acute respiratory distress syndrome patients and their clinical significance in pulmonary structural remodeling
- (2019) Yongpeng Xie et al. MEDICINE
- Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
- (2019) Gandhi T. K. Boopathy et al. Frontiers in Cell and Developmental Biology
- Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
- (2019) Toby M Maher et al. Lancet Respiratory Medicine
- Vitamin D–VDR Signaling Inhibits Wnt/β-Catenin–Mediated Melanoma Progression and Promotes Antitumor Immunity
- (2019) Sathya Muralidhar et al. CANCER RESEARCH
- Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
- (2019) Andrew J. Haak et al. Science Translational Medicine
- Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway
- (2018) Xiaoguang Zhao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phosphatidylinositol 3‐Kinase–DNA Methyltransferase 1–miR‐1281–Histone Deacetylase 4 Regulatory Axis Mediates Platelet‐Derived Growth Factor–Induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells
- (2018) Yanjiao Li et al. Journal of the American Heart Association
- The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury
- (2018) Anandharajan Rathinasabapathy et al. Frontiers in Physiology
- The Antifibrotic Activity of Prostacyclin Receptor Agonism is Mediated through Inhibition of YAP/TAZ
- (2018) Katarina Zmajkovicova et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The Hippo Pathway: Biology and Pathophysiology
- (2018) Shenghong Ma et al. Annual Review of Biochemistry
- YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer
- (2018) Satoshi Noguchi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epithelial-derived TGF-β1 acts as a pro-viral factor in the lung during influenza A infection
- (2017) L Denney et al. Mucosal Immunology
- Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics
- (2017) Roya Tabatabai et al. Targeted Oncology
- SARS coronavirus papain-like protease up-regulates the collagen expression through non-Samd TGF-β1 signaling
- (2017) Ching-Ying Wang et al. VIRUS RESEARCH
- BreathDx – molecular analysis of exhaled breath as a diagnostic test for ventilator–associated pneumonia: protocol for a European multicentre observational study
- (2017) Pouline M. P. van Oort et al. BMC Pulmonary Medicine
- Pirfenidone Inhibits Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway
- (2017) Wei-Jie Zou et al. MEDICAL SCIENCE MONITOR
- Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
- (2017) Michiru Nishita et al. Scientific Reports
- Lrp5/β-catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis
- (2016) Joseph A Sennello et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
- (2016) Valentina Cappello et al. Scientific Reports
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection: Chest CT Findings
- (2014) Amr M. Ajlan et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
- (2014) Yoshito Takeda et al. Patient Preference and Adherence
- The Hippo pathway: regulators and regulations
- (2013) F.-X. Yu et al. GENES & DEVELOPMENT
- Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study
- (2013) Pierre-Olivier Bridevaux et al. THORAX
- PAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury
- (2012) John J Osterholzer et al. JOURNAL OF PATHOLOGY
- Pirfenidone
- (2011) Natalie J. Carter DRUGS
- Pyrvinium, a Potent Small Molecule Wnt Inhibitor, Promotes Wound Repair and Post-MI Cardiac Remodeling
- (2010) Sarika Saraswati et al. PLoS One
- Pirfenidone in idiopathic pulmonary fibrosis
- (2009) H. Taniguchi et al. EUROPEAN RESPIRATORY JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started